Sex Differences in Subclinical Atherosclerosis and Systemic Immune Activation/Inflammation Among People With Human Immunodeficiency Virus in the United States
Markella V. Zanni(Harvard University), Steven Grinspoon(Massachusetts General Hospital), Heather J. Ribaudo(Cancer Research And Biostatistics), Carl J. Fichtenbaum(Cancer Research And Biostatistics), Edgar T. Overton(University of Alabama at Birmingham), Babafemi Taiwo, Thomas Campbell(University of Colorado Anschutz Medical Campus), Udo Hoffmann(Duke Medical Center), Patrick Autissier(Beth Israel Deaconess Medical Center), Borek Foldyna(Cancer Research And Biostatistics), Sara E. Looby(Cancer Research And Biostatistics), Pamela S. Douglas(Duke University), Grant Ellsworth(Cornell University), Evelynne S. Fulda(Cancer Research And Biostatistics), Michael T. Lu(Cancer Research And Biostatistics), Carlos Malvestutto(The Ohio State University Wexner Medical Center), Gerald S. Bloomfield, Tricia H. Burdo(Temple University), Judith S. Currier(University of California, Los Angeles), Kathleen V. Fitch(Harvard University), Sara McCallum(Cancer Research And Biostatistics), Anandi N. Sheth(Emory University), Judith A. Aberg(Icahn School of Medicine at Mount Sinai), Kristine M. Erlandson(University of Colorado Denver)
Cited by 21
Related Papers
Prevention of HIV-1 Infection with Early Antiretroviral Therapy
|New England Journal of Medicine|2011|7k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial
|The Lancet|2018|1.8k
Increased Acute Myocardial Infarction Rates and Cardiovascular Risk Factors among Patients with Human Immunodeficiency Virus Disease
|The Journal of Clinical Endocrinology & Metabolism|2007|1.6k